According to the National Organization of Rare Diseases (NORD), a rare disease is one that affects fewer than 200,000 Americans at any given time. According to the National Institutes of Health, there are between 6,000 and 7,000 rare diseases affecting from 25 to 30 million Americans. Approximately 50% of the people affected by rare diseases are children. The NORD website has physician guides to many of these diseases aimed at primary care practitioners (http://nordphysicianguides.org/).
Dr. Able discusses the migraineurs attending college and the new stressors they face in their new environment. Strategies can be planned that help them cope with their migraines which can prevent the transformation of migraine from episodic to chronic. Counseling centers can also assist the students in regaining a sense of confidence by finding solutions to these problems
Healthcare providers often find it difficult to provide mental health help for their patients because they don’t know where to start. Dr. Charles Sneiderman provides numerous sources for patients and family education.
Dr. Charles Sneiderman reviews the responsibility of both the patient and healthcare provider in conforming to the new Electronic Medical Records (EMR) required by the Health Information Privacy and Accessibility Act (HIPAA).
Electronic medical record systems have been adopted in most primary care practices, yet many practitioners are disappointed with the EMR systems they are using. Dr. Charles Sneiderman has some insights into what happened and what you can do about it.
The FDA, on February 25, 2015 issued a new safety announcement for the revision of the label for diabetic pens and packaging of multiple doses to carry a warning label stating, “For single patient use only”.
Dr. Able discusses a first of its kind, recently FDA approved medical device for migraines. This device offers external cranial neurostimulation giving migraine patients a non-invasive, drug free alternative to reducing migraine headaches.